ylisabeth bradshaw d-tree

Ylisabeth Bradshaw

Ylisabyth Bradshaw, DO, MS is Academic Director of the Masters of Science in Pain Research, Education and Policy at Tufts University School of Medicine. Dr. Bradshaw’s research includes innovations in medical and public health education, medication adherence for people taking ARV’s, and on overcoming barriers to effective health communication. She teaches change in organizations and systems for graduate students in Tufts’ Public Health and Professional Degree Programs, and is an Assistant Professor in the Department of Public Health and Family Medicine at Tufts University School of Medicine.

Barbara Bulc

Barbara Bulc

Barbara Bulc is the founder and president of Global Development. She has over 20 years of leadership and advisory experience in international development, global health, diplomacy and the pharmaceutical industry, working with the private sector, governments, international organization and NGOs in Europe, the U.S, Africa and Asia.

Mrs. Bulc has been a driving force in catalyzing and developing innovative and transformative public-private partnerships in development to improve people’s lives. She was a Senior Advisor and a founding management team member at the President Bill Clinton Foundation in New York where she focused on developing innovative large scale sustainable partnerships with governments, industry, international organizations and financing institutions in emerging economies to reduce poverty. She was instrumental in developing the Clinton Foundation’s HIV/AIDS Initiative, which provides access to affordable and equitable healthcare to over 60 countries.

She established and led Ambassador Richard Holbrooke’s European office of the Global Business Coalition in Geneva, mobilizing the power of business and Fortune 500 corporations in the global fight against poverty. In this role Mrs. Bulc served as a representative of the private sector on various international boards, including the Global Fund, a multibillion-dollar innovative public-private partnerships.

Preceding her career in international development, Mrs. Bulc was the CEO of KRKA Pharmaceuticals U.S. in New York, one of the leading European generics companies. She worked in various positions with Novartis (Switzerland), Knoll, and BASF (Germany). Mrs. Bulc was elected to the Board of Directors of the U.S. Generic Pharmaceutical Industry Association (GPhA) and served on the Board of Bionor Immuno (Norway).

She is a founding member of a pan-African organization, Friends of the Global Fund, Africa and a member of the United Nations’ Innovation Working Group, a group that drives innovation and change in support of the UN Secretary General’s transformational Every Woman Every Child movement.

Mrs. Bulc holds graduate degrees in chemistry and management from Ljubljana University in Slovenia and Columbia University Business School in New York. She speaks English, French, German, Slovene and Serbo-Croatian. She was born in Ljubljana, Slovenia, and has lived and worked in New York, the U.S. and in several other countries. She currently lives in Geneva, Switzerland.

Margaret Hume d-tree

Margaret Hume

Margaret Hume is a Principal Associate at Management Sciences for Health, having held key strategy and management roles in the organization over the past 20 years. As Director of New Business Development, she provided leadership for the strategic development of technical and cost proposals for USAID, other bilateral and multilateral donor agencies, and foundations. She has also provided technical assistance in strategic and financial planning, organizational development, and evaluation through MSH field projects in Asia, Africa, and the Caribbean; and has extensive experience as a management trainer. Ms. Hume holds masters degrees from Harvard University School of Public Health and from Stanford Business School.

Milton Kotelchuck d-tree

Milton Kotelchuck

Dr. Milton Kotelchuck is Professor of Public Health at Boston University School of Public Health and holds joint appointments at the School of Medicine in Pediatrics and OB/GYN (MED). Dr. Kotelchuck has extensive experience evaluating public health programs to improve birth outcomes and child health status. His research interests include examination of the adequacy and content of prenatal care, racial disparities in birth outcomes, maternal morbidity, immigrant health, child health services, and health data policy. He developed the widely used Adequacy of Prenatal Care Utilization Index. Dr. Kotelchuck serves on numerous national committees to improve perinatal and child health services, including Chairman of the Technical Expert Panel on Evaluation of Healthy Start. Previously, he served as Director of the Division of Health Statistics and Research and then Assistant Commissioner for Community Health Services, Massachusetts Department of Public Health, and was a member of the Massachusetts and North Carolina Governor’s Commissions on the Reduction of Infant Mortality. Dr. Kotelchuck is the Founding and Senior Editor of the Maternal and Child Health Journal. He holds an MPH in maternal and child health and epidemiology and a PhD in personality and developmental psychology.

Barbara Mitchell d-tree

Barbara Mitchell

Barbara Mitchell is the Executive Director of Cambridge Legal Services and Counseling Center in Cambridge Massachusetts. Whe was previously the Managing Attorney of the Family Law Unit at Greater Boston Legal Services (GBLS), where she worked for more than twenty years. She has experience working on women’s issues, including access to health care, in Papua New Guinea, Tanzania, Indonesia, and Mexico. She has a BA from University of Michigan, JD from Boston University Law School, and an LLM from Harvard Law School with a concentration in law and third world development.

Ashton Peery

Ashton Peery

Ashton is an experienced CEO, investor and high-tech consultant. As an entrepreneur he was CEO of Renesys, an Internet analytics business, and previously CEO of Top10 Media, an Internet content business, leading both to successful exits. He is a former General Partner of Lucent Venture Partners, which invested in high-tech startups across the industry. Prior to this he served as the Chief Strategy Officer and head of Business Development at Lucent Technologies where he shepherded 21 acquisitions and their integration and helped create several new lines of business. In consulting, Ashton was Managing Director of GeoPartners Research, a thought-leading technology strategy consultancy. Early in his career, he was a public television Producer, Director and Writer. Throughout his career, Ashton has personally invested in promising startups and served on the Boards of many. Ashton holds a Bachelor of Arts and a Master in Business Administration from Harvard University, both with honors.

H. David Sherman

H. David Sherman is a tenured Professor of Accounting at Northeastern University’s College of Business Administration and is a CPA. He has served on the faculty of the MIT Sloan School of Management and as a visiting faculty member at INSEAD, in Fontainebleau, France, and the Naval Postgraduate School, in Monterey, California. David was the Academic Fellow in the Division of Corporate Finance of the Securities and Exchange Commission, in Washington, D.C., during the year ending July 2005. David co-authored “The Audit Committee’s New Agenda,” which appeared in the Harvard Business Review (June 2009). He is also co-author of Profits You Can Trust: Spotting and Surviving Accounting Landmines, also published in a Chinese edition. He has been an invited speaker on U.S. and international shareholder reporting issues at national professional and academic meetings in the United States, South America, Europe, China, and Japan. David also works on managing service productivity and the use of a technique referred to as “Data Envelopment Analysis.” His book Service Productivity Management: Improving Service Performance using Data Envelopment Analysis, published in 2006, includes applications to financial services, health care, and government services. He has also served as a director and manager of several businesses, and has consulted on financial performance issues with major corporations, banks, and the Financial Accounting Standards Board. David holds an MBA and Doctorate degree from Harvard Business School and an AB in Economics from Brandeis University.